Citadel Advisors’s MEDASSETS INC COM STK (DE) MDAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-5,700
Closed -$176K 9127
2015
Q4
$176K Buy
5,700
+4,000
+235% +$111K ﹤0.01% 5974
2015
Q3
$34K Sell
1,700
-5,400
-76% -$115K ﹤0.01% 7845
2015
Q2
$157K Sell
7,100
-4,300
-38% -$89.7K ﹤0.01% 6618
2015
Q1
$215K Buy
11,400
+7,600
+200% +$145K ﹤0.01% 6095
2014
Q4
$75K Buy
3,800
+2,700
+245% +$54.8K ﹤0.01% 6907
2014
Q3
$23K Buy
+1,100
New +$24.6K ﹤0.01% 7353
2014
Q2
Sell
-2,800
Closed -$69K 8612
2014
Q1
$69K Buy
+2,800
New +$63.1K ﹤0.01% 6509
2013
Q4
Sell
-2,100
Closed -$53K 7344
2013
Q3
$53K Sell
2,100
-100
-5% -$2.24K ﹤0.01% 5771
2013
Q2
$39K Buy
+2,200
New +$39.5K ﹤0.01% 5792

Citadel Advisors's MDAS Position: Q1 2016 in Review

Citadel Advisors sold out of MEDASSETS INC COM STK (DE) (MDAS) in Q1 2016, closing a stake of 7,657 shares — an estimated $237K sold.

Citadel Advisors first reported a position in MDAS in Q2 2013 and held it in 11 quarters. The position peaked at $8.46M in Q1 2015. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.

  • Citadel Advisors reported no remaining MEDASSETS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Citadel Advisors sold 7,657 MEDASSETS INC COM STK (DE) shares in Q1 2016, an estimated $237K.
  • Citadel Advisors first reported a position in MEDASSETS INC COM STK (DE) in Q2 2013 and held it in 11 quarters.
  • Citadel Advisors's MEDASSETS INC COM STK (DE) position peaked at $8.46M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held MEDASSETS INC COM STK (DE) as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.